Table 1.

Determination of the zoonotic potential of feline, bovine and equine foamy virus

1	Establishing species‐specific and group‐specific screening systems for high‐throughput analysis of human serum samples (e.g. enzyme‐ linked immuno‐sorbent assay, ELISA)
2	Establishing confirmatory, species‐specific serological test (e.g. immuno‐blotting tests)
3	Establishing independent, PCR‐based detection systems
4	Testing of samples from individuals with increased exposition probability
5	Testing of samples from patients where exposition to cat, bovine, or equine viruses has been implicated in disease